rhinogard bovine herpesvirus 1 live intranasal vaccine for cattle
zoetis australia pty ltd - bovine herpesvirus 1 - misc. aural, ophthalmic, oro/naso pharyngeal - bovine herpesvirus 1 vaccine-viral active 0.0 p - immunotherapy - cattle - feedlot | beef | bovine | dairy cow - bovine herpesvirus | vaccine | equine rotavirus
rhinogard bovine herpesvirus 1 live intranasal liquid vaccine for cattle
zoetis australia pty ltd - bovine herpesvirus 1 - topical aerosol spray - bovine herpesvirus 1 vaccine-viral active 0.0 p - immunotherapy - cattle - feedlot | beef | bovine | dairy cow - bovine herpesvirus | promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain
bles (bovine lipid extract surfactant) 27 mgml suspension for intratracheal instillation
averroes pharmaceuticals sdn. bhd. - bovine lipids extract surfactant -
coopers bovilis mh + ibr bovine respiratory disease (brd) vaccine
intervet australia pty limited - inactivated bovine herpes virus type 1.2b; inactivated mannheimia haemolytica strain x387; inactivated m. haemolytica leucotoxin strain x332 - misc. vaccines or anti sera - inactivated bovine herpes virus type 1.2b vaccine-viral active 0.0 m org/ml; inactivated mannheimia haemolytica strain x387 vaccine - general active 0.0 m org/ml; inactivated m. haemolytica leucotoxin strain x332 vaccine - general active 1.0e8 orgs/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine herpesvirus | bovine respiratory disease | shipping fever
ultravac bef vaccine
zoetis australia pty ltd - bovine ephemeral fever virus (befv) - parenteral liquid/solution/suspension - bovine ephemeral fever virus (befv) vaccine-viral active 0.0 p - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine ephemeral fever (bef) | vaccine | equine rotavirus | three day sickness
survanta
abbvie limited - bovine lung lipids 25 mg/ml (total phospholipids); colfosceril palmitate 11 mg/ml - 15.5 mg/ml (disaturated phosphatidylcholine); palmitic acid 1.4 mg/ml - 3.5 mg/ml (free fatty acid); tripalmitin 0.5 mg/ml - 1.75 mg/ml (triglycerides) - intratracheal suspension - 25 mg/ml - active: bovine lung lipids 25 mg/ml (total phospholipids) colfosceril palmitate 11 mg/ml - 15.5 mg/ml (disaturated phosphatidylcholine) palmitic acid 1.4 mg/ml - 3.5 mg/ml (free fatty acid) tripalmitin 0.5 mg/ml - 1.75 mg/ml (triglycerides) excipient: sodium chloride water for injection - survanta is indicated for prevention and treatment ("rescue") of respiratory distress syndrome (rds) (hyaline membrane disease) in premature infants. survanta significantly reduces the incidence of rds, mortality due to rds and air leak complications.
newfactan 120 mg powder for solution for intratracheal infusion
unimex, inc.; distributor: largen med., inc. - bovine lung surfactant - powder for solution for intratracheal infusion - 120 mg
newfactan 120 mg powder for solution for intratracheal infusion
; importer: unimex, inc.; distributor: largen med., inc. - bovine lung surfactant - powder for solution for intratracheal infusion - 120 mg
coopers bovilis ibr infectious bovine rhinotracheitis(ibr) vaccine for cattle
intervet australia pty limited - inactivated bovine herpes virus type 1.2b - misc. vaccines or anti sera - inactivated bovine herpes virus type 1.2b vaccine-viral active 0.0 orgs/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine respiratory disease | infectious bovine rhinotracheitis (ibr) | shipping fever
coopers bovilis rotavec corona calf scours vaccine
intervet australia pty limited - bovine rotavirus (ncdv); clostridium perfringens type c toxoid; escherichia coli k99 pilus antigens; clostridium perfringens type d toxoid; bovine coronavirus (inactivated) - misc. vaccines or anti sera - bovine rotavirus (ncdv) biological-virus active 1.0 rp; clostridium perfringens type c toxoid vaccine-toxoid active 10.0 iu/ml; escherichia coli k99 pilus antigens vaccine-microbial active 1.0 rp; clostridium perfringens type d toxoid vaccine-toxoid active 2.0 iu/ml; bovine coronavirus (inactivated) vaccine-viral active 1.0 rp - immunotherapy - cow | healthy pregnant heifer | bovine | female cattle - bovine rotaviruses | neonatal calf diarrhea | neonatal enterotoxemia | raise colostral antibodies | against bovine rotavirus and | coronavirus | enterotoxigenic e.coli pilus | g6 and g10 | type k99